Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Health Syst Pharm ; 76(15): 1122-1126, 2019 Jul 18.
Article in English | MEDLINE | ID: mdl-31408514
2.
Pak J Med Sci ; 32(5): 1071-1076, 2016.
Article in English | MEDLINE | ID: mdl-27881996

ABSTRACT

OBJECTIVE: To assess and evaluate the drug storage quality and regulatory compliance among privately operated drug stores of Karachi Pakistan. METHODS: A cross-sectional survey of drug stores located in Karachi was conducted from May to December 2013. A total of 1003 drug stores that were involved in the sales, purchase and dispensing of pharmaceutical products were approached by non-probability purposive sampling technique, and the information was collected using a close ended, structured questionnaire. RESULTS: Out of 1003 drug stores inspected only 4.1%(n=41) were found compliant to regulatory requirements. Most of the stores 74.9%(n=752) were selling general items along with the drugs. Only 12%(n=124) stores were having qualified person working on the store, out of which 33% were pharmacist. 47.4%(n=400) of the stores had drug sales license displayed in the premises and 33.4%(n=282) of the stores had expired drug sales license. 11.4%(n=94) stores were found selling vaccines without proper refrigerator and only 11.7% stores had the power backup for the refrigerator. Only 40.2%(n=403) of stores were protected from direct sunlight and 5.4%(n=54) having air conditioning in the premises. CONCLUSION: The regulatory compliance of majority of the drug stores operated privately in different areas of Karachi is below standard. Only a few drugs stores have adequate facilities to protect the drugs from extreme temperature, sunlight and provision of refrigeration. Very few of the drug stores carry out drug sales under the supervision of qualified pharmacist. There is a dire need to improve the storage practices in the drug stores by complying with the regulatory standards/laws as specified by the Drug Regulatory Authority of Pakistan.

3.
Am J Health Syst Pharm ; 73(14): 1077-86, 2016 Jul 15.
Article in English | MEDLINE | ID: mdl-27189856

ABSTRACT

PURPOSE: The processes used to revise the 2008 Basel Statements on the future of hospital pharmacy are summarized, and the revised statements are presented. METHODS: The process for revising the Basel Statements followed an approach similar to that used during their initial development. The Hospital Pharmacy Section (HPS) of the International Pharmaceutical Federation (FIP) revised the 2008 FIP Basel Statements in four phases, including a survey of hospital pharmacists worldwide, an internal review, online forums, and a face-to-face "World Café" workshop in Bangkok, Thailand. RESULTS: The global survey on the initial Basel Statements included input from 334 respondents from 62 countries. The majority of respondents agreed that most of the initial Basel Statements were acceptable as written and did not require revision. In total, 11 statements were judged by more than 10% of respondents as needing revision or deletion. The FIP HPS executive committee used the survey results to develop 69 initial revised draft statements. After an online discussion with the international hospital pharmacy community, including individuals from 28 countries representing all six World Health Organization regions, a final set of draft statements was prepared for the live discussion involving participants from 20 countries. The final 65 revised Basel Statements were voted on and accepted. CONCLUSION: Systematic revision of the FIP Basel Statements resulted in an updated reflection of aspirational goals for the future of hospital pharmacy practice. While this revision reflects the development of new goals for hospital pharmacy practice, the core principles of the Basel Statements remain an essential foundation for the discipline.


Subject(s)
Internationality , Pharmacy Service, Hospital/standards , Pharmacy Service, Hospital/trends , Societies, Pharmaceutical/standards , Societies, Pharmaceutical/trends , Congresses as Topic/trends , Forecasting , Humans , Surveys and Questionnaires , Switzerland , Thailand
4.
East Mediterr Health J ; 12 Suppl 1: S42-9, 2006.
Article in English | MEDLINE | ID: mdl-17037688

ABSTRACT

A great deal of pharmaceutical research is nowadays carried out in developing countries such as Pakistan. Is it, however, beneficial for the country and the participants, often the poorly educated and illiterate? Pharmaceutical research in Pakistan can bring benefits to both patients and country. Promotion of good clinical practice and the development of national guidelines are advocated. Government and industry both have a role to play to maintain the right balance.


Subject(s)
Clinical Trials as Topic/ethics , Developing Countries , Drug Industry/ethics , Ethics, Research , Benchmarking , Drug Industry/organization & administration , Ethics Committees, Research/ethics , Ethics Committees, Research/organization & administration , Government Regulation , Guidelines as Topic , Health Policy , Health Services Needs and Demand , Human Experimentation/ethics , Humans , Interinstitutional Relations , Marketing of Health Services/ethics , Marketing of Health Services/organization & administration , Pakistan , Research Support as Topic/ethics , Research Support as Topic/organization & administration
SELECTION OF CITATIONS
SEARCH DETAIL
...